Dual specificity protein kinase 3D structures
From Proteopedia
(Difference between revisions)
(New page: ==3D structures of dual specificity protein kinase== Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *CLK1 kinase d...) |
|||
| Line 8: | Line 8: | ||
**[[1z57]] – hCLK1 + himenialdizine – human | **[[1z57]] – hCLK1 + himenialdizine – human | ||
| - | **[[5j1v]], [[5j1w]], [[2vag]], [[5x8i]], [[6raa]], [[6q8p]], [[6q8k]], [[6i5l]], [[6i5k]], [[6i5i]], [[6i5h]], [[6fyo]], [[6ft9]], [[6ft8]] – hCLK1 + inhibitor<br /> | + | **[[5j1v]], [[5j1w]], [[2vag]], [[5x8i]], [[6raa]], [[6q8p]], [[6q8k]], [[6i5l]], [[6i5k]], [[6i5i]], [[6i5h]], [[6fyo]], [[6ft9]], [[6ft8]], [[6khd]], [[6qty]], [[6r3d]], [[6r6e]], [[6r6x]], [[6r8j]]. [[6tw2]], [[6yta]], [[6yte]], [[6ytg]], [[6yth]], [[6yti]], [[6z4z]], [[6z50]] – hCLK1 + inhibitor<br /> |
| + | **[[6ytd]] – hCLK1 (mutant) + inhibitor<br /> | ||
**[[6g33]] – hCLK1 + iodotubercidine inhibitor<br /> | **[[6g33]] – hCLK1 + iodotubercidine inhibitor<br /> | ||
| Line 14: | Line 15: | ||
**[[3nr9]] – hCLK2<br /> | **[[3nr9]] – hCLK2<br /> | ||
| - | **[[5unp]], [[6fyl]], [[6fyk]], [[6fyi]] – hCLK2 + inhibitor<br /> | + | **[[5unp]], [[6fyl]], [[6fyk]], [[6fyi]], [[6khe]] – hCLK2 + inhibitor<br /> |
*CLK3 | *CLK3 | ||
| Line 22: | Line 23: | ||
**[[2exe]] – hCLK3 kinase domain, phosphorylated | **[[2exe]] – hCLK3 kinase domain, phosphorylated | ||
| - | **[[2wu6]], [[2wu7]], [[6rct]], [[6fyr]], [[6fyp]], [[6ft7]] - hCLK3 kinase domain + inhibitor | + | **[[2wu6]], [[2wu7]], [[6rct]], [[6fyr]], [[6fyp]], [[6ft7]], [[6khf]], [[6ytw]], [[6yu1]], [[6z51]], [[6z52]], [[6z53]], [[6z54]], [[6z55]] - hCLK3 kinase domain + inhibitor<br /> |
| - | + | **[[6yty]] – hCLK3 (mutant) + inhibitor<br /> | |
**[[3raw]] - hCLK3 kinase domain + leucettine | **[[3raw]] - hCLK3 kinase domain + leucettine | ||
| Line 38: | Line 39: | ||
**[[3h9f]] - hTTK kinase domain + pyrimidino-diazepin ligand | **[[3h9f]] - hTTK kinase domain + pyrimidino-diazepin ligand | ||
| - | **[[2x9e]], [[3vqu]], [[3w1f]], [[4bhz]], [[4bi0]], [[4bi1]], [[4bi2]], [[4c4e]], [[4c4f]], [[4c4g]], [[4c4h]], [[4c4i]], [[4c4j]], [[4js8]], [[4jt3]], [[3wzj]], [[3wzk]], [[4o6l]], [[5ehl]], [[5eho]], [[5ehy]], [[5ei2]], [[5ei6]], [[5ei8]], [[5ap0]], [[5ap1]], [[5ap2]], [[5eh0]], [[4zeg]], [[6b4w]], [[5na0]], [[5n9s]], [[5n93]], [[5n87]], [[5n84]], [[5n7v]], [[6h3k]], [[6n6o]], [[4d2s]], [[4cva]], [[4cv9]], [[4cv8]], [[3wyy]], [[3wyx]] - hTTK kinase domain + inhibitor | + | **[[2x9e]], [[3vqu]], [[3w1f]], [[4bhz]], [[4bi0]], [[4bi1]], [[4bi2]], [[4c4e]], [[4c4f]], [[4c4g]], [[4c4h]], [[4c4i]], [[4c4j]], [[4js8]], [[4jt3]], [[3wzj]], [[3wzk]], [[4o6l]], [[5ehl]], [[5eho]], [[5ehy]], [[5ei2]], [[5ei6]], [[5ei8]], [[5ap0]], [[5ap1]], [[5ap2]], [[5eh0]], [[4zeg]], [[6b4w]], [[5na0]], [[5n9s]], [[5n93]], [[5n87]], [[5n84]], [[5n7v]], [[6h3k]], [[6n6o]], [[4d2s]], [[4cva]], [[4cv9]], [[4cv8]], [[3wyy]], [[3wyx]], [[6tn9]], [[6tnb]], [[6tnc]], [[6tnd]] - hTTK kinase domain + inhibitor |
**[[2zmd]], [[5ap3]], [[5ap4]], [[5ap5]], [[5ap6]], [[5ap7]], [[5o91]], [[5ntt]], [[5nad]], [[5mrb]] - hTTK kinase domain (mutant) + inhibitor<br /> | **[[2zmd]], [[5ap3]], [[5ap4]], [[5ap5]], [[5ap6]], [[5ap7]], [[5o91]], [[5ntt]], [[5nad]], [[5mrb]] - hTTK kinase domain (mutant) + inhibitor<br /> | ||
Revision as of 07:03, 20 July 2020
3D structures of dual specificity protein kinase
Updated on 20-July-2020
